Literature DB >> 26018603

Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.

Hugo González1, Francisco Contreras1, Rodrigo Pacheco2,3.   

Abstract

Neuroinflammation constitutes a fundamental process involved in the physiopathology of Parkinson's disease (PD). Microglial cells play a central role in the outcome of neuroinflammation and consequent neurodegeneration of dopaminergic neurons in the substantia nigra. Current evidence indicates that CD4+ T-cells infiltrate the central nervous system (CNS) in PD, where they play a critical role determining the functional phenotype of microglia, thus regulating the progression of the neurodegenerative process. Here, we first analysed the pathogenic role of inflammatory phenotypes and the beneficial role of anti-inflammatory phenotypes of encephalitogenic CD4+ T-cells involved in the physiopathology of PD. Next, we discussed how alterations of neurotransmitter levels observed in the basal ganglia throughout the time course of PD progression could be strongly affecting the behaviour of encephalitogenic CD4+ T-cells and thereby the outcome of the neuroinflammatory process and the consequent neurodegeneration of dopaminergic neurons. Afterward, we integrated the evidence indicating the involvement of an antigen-specific immune response mediated by T-cells and B-cells against CNS-derived self-constituents in PD. Consistent with the involvement of a relevant autoimmune component in PD, we also reviewed the polymorphisms of both, class I and class II major histocompatibility complexes, associated to the risk of PD. Overall, this study gives an overview of how an autoimmune component involved in PD plays a fundamental role in the progression of the neurodegenerative process.

Entities:  

Keywords:  Autoimmunity; CD4+ T-cells; Neuroinflammation; Neurotransmitters; Parkinson’s disease

Mesh:

Year:  2015        PMID: 26018603     DOI: 10.1007/s11481-015-9618-9

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  134 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Interferon-γ plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways.

Authors:  Emily N Mangano; Darcy Litteljohn; Remmick So; Eric Nelson; Sarah Peters; Cheri Bethune; Jessica Bobyn; Shawn Hayley
Journal:  Neurobiol Aging       Date:  2011-04-11       Impact factor: 4.673

3.  MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease.

Authors:  I Kurkowska-Jastrzebska; A Wrońska; M Kohutnicka; A Członkowski; A Członkowska
Journal:  Acta Neurobiol Exp (Wars)       Date:  1999       Impact factor: 1.579

4.  Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.

Authors:  Zizhen Kang; Cengiz Zubeyir Altuntas; Muhammet Fatih Gulen; Caini Liu; Natalia Giltiay; Hongwei Qin; Liping Liu; Wen Qian; Richard M Ransohoff; Cornelia Bergmann; Stephen Stohlman; Vincent K Tuohy; Xiaoxia Li
Journal:  Immunity       Date:  2010-03-18       Impact factor: 31.745

5.  Glutamate released by dendritic cells as a novel modulator of T cell activation.

Authors:  Rodrigo Pacheco; Harold Oliva; José M Martinez-Navío; Núria Climent; Francisco Ciruela; José M Gatell; Teresa Gallart; Josefa Mallol; Carmen Lluis; Rafael Franco
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

6.  CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging.

Authors:  Kuti Baruch; Noga Ron-Harel; Hilah Gal; Aleksandra Deczkowska; Eric Shifrut; Wilfred Ndifon; Nataly Mirlas-Neisberg; Michal Cardon; Ilan Vaknin; Liora Cahalon; Tamara Berkutzki; Mark P Mattson; Fernando Gomez-Pinilla; Nir Friedman; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-18       Impact factor: 11.205

Review 7.  Basal ganglia macrocircuits.

Authors:  J M Tepper; E D Abercrombie; J P Bolam
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

8.  Astrocytes modulate the polarization of CD4+ T cells to Th1 cells.

Authors:  Eléonore Beurel; Laurie E Harrington; William Buchser; Vance Lemmon; Richard S Jope
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

Review 9.  Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.

Authors:  Kristi M Anderson; Katherine E Olson; Katherine A Estes; Ken Flanagan; Howard E Gendelman; R Lee Mosley
Journal:  Transl Neurodegener       Date:  2014-11-13       Impact factor: 8.014

10.  Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes.

Authors:  Vincent Goëb; Marlène Thomas-L'Otellier; Romain Daveau; Roland Charlionet; Patrice Fardellone; Xavier Le Loët; François Tron; Danièle Gilbert; Olivier Vittecoq
Journal:  Arthritis Res Ther       Date:  2009-03-10       Impact factor: 5.156

View more
  26 in total

1.  Peripheral Blood Monocyte Tolerance Alleviates Intraperitoneal Lipopolysaccharides-Induced Neuroinflammation in Rats Via Upregulating the CD200R Expression.

Authors:  Liping Xia; Xin Xie; Yang Liu; Xiaoguang Luo
Journal:  Neurochem Res       Date:  2017-06-29       Impact factor: 3.996

2.  Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.

Authors:  Xinrong Liu; Shuya Liu; Yong Tang; Zhengjia Pu; Hong Xiao; Jieying Gao; Qi Yin; Yan Jia; Qunhua Bai
Journal:  Neurochem Res       Date:  2021-03-15       Impact factor: 3.996

Review 3.  Immune cell regulation of glia during CNS injury and disease.

Authors:  Andrew D Greenhalgh; Sam David; F Chris Bennett
Journal:  Nat Rev Neurosci       Date:  2020-02-10       Impact factor: 34.870

Review 4.  The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease.

Authors:  Runing Yang; Ge Gao; Hui Yang
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

5.  Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.

Authors:  Hongwei Qin; Jessica A Buckley; Xinru Li; Yudong Liu; Thomas H Fox; Gordon P Meares; Hao Yu; Zhaoqi Yan; Ashley S Harms; Yufeng Li; David G Standaert; Etty N Benveniste
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

Review 6.  Targeting the Dopaminergic System in Autoimmunity.

Authors:  Pia M Vidal; Rodrigo Pacheco
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-19       Impact factor: 4.147

Review 7.  Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.

Authors:  R Lee Mosley
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-26       Impact factor: 4.147

8.  Caprylic acid ameliorates rotenone induced inflammation and oxidative stress in the gut-brain axis in Zebrafish.

Authors:  Derya Cansız; İsmail Ünal; Ünsal Veli Üstündağ; Ahmet Ata Alturfan; Meriç A Altinoz; İlhan Elmacı; Ebru Emekli-Alturfan
Journal:  Mol Biol Rep       Date:  2021-07-06       Impact factor: 2.316

Review 9.  CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways.

Authors:  Seyed Mohammad Gheibihayat; Ricardo Cabezas; Nikita G Nikiforov; Tannaz Jamialahmadi; Thomas P Johnston; Amirhossein Sahebkar
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

Review 10.  The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.

Authors:  Ana I Ramirez; Rosa de Hoz; Elena Salobrar-Garcia; Juan J Salazar; Blanca Rojas; Daniel Ajoy; Inés López-Cuenca; Pilar Rojas; Alberto Triviño; José M Ramírez
Journal:  Front Aging Neurosci       Date:  2017-07-06       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.